TCL Archive NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review February 13, 1987
TCL Archive High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I April 27, 2001
TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
